Bullous herpes zoster

J Pediatr. 2014 Mar;164(3):667. doi: 10.1016/j.jpeds.2013.10.026. Epub 2013 Nov 16.

Authors

Ke Juin Wong¹, Joshua Osowicki¹, Eleanor Seaby¹, Nigel Curtis², Amanda Gwee¹

Affiliations

¹ Infectious Diseases Unit, Department of General Medicine, The Royal Children's Hospital, Melbourne, Parkville, Victoria, Australia.
² Infectious Diseases Unit, Department of General Medicine, The Royal Children's Hospital, Melbourne, Parkville, Victoria, Australia; Murdoch Children's Research Institute, Melbourne, Parkville, Victoria, Australia; Department of Pediatrics, The University of Melbourne, Melbourne, Parkville, Victoria, Australia.

PMID: 24252791
DOI: 10.1016/j.jpeds.2013.10.026

No abstract available

Publication types

Case Reports

MeSH terms

Adolescent
Anti-Bacterial Agents / therapeutic use
Antiviral Agents / therapeutic use
Arthritis, Juvenile / complications
Female
Floxacillin / therapeutic use
Foscarnet / therapeutic use
Herpes Zoster / complications
Herpes Zoster / diagnosis*
Herpes Zoster / drug therapy
Herpesvirus 3, Human / genetics
Herpesvirus 3, Human / isolation & purification
Humans
Polymerase Chain Reaction
Skin Diseases, Vesiculobullous / drug therapy
Skin Diseases, Vesiculobullous / pathology*
Skin Diseases, Vesiculobullous / virology*
Staphylococcal Infections / diagnosis*
Staphylococcal Infections / drug therapy

Substances

Anti-Bacterial Agents
Antiviral Agents
Foscarnet
Floxacillin